Authors' reply.
作者信息
Moschos John M, Kouklakis George, Zavos Christos, Kountouras Jannis
机构信息
Medical School Democritus University of Thrace, Alexandroupolis (John Moschos, George Kouklakis), Greece.
Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki (Christos Zavos, Jannis Kountouras), Greece.
出版信息
Ann Gastroenterol. 2015 Apr-Jun;28(2):294-295.
Abstract
摘要
相似文献
1
Authors' reply.
Ann Gastroenterol. 2015 Apr-Jun;28(2):294-295.
2
Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.
Appl Opt. 1985 Apr 1;24(7):944. doi: 10.1364/AO.24.000944.
3
Authors' reply: Comment on authors' reply: Patients' perception of risk: informed choice in prenatal testing for foetal aneuploidy.
Singapore Med J. 2013 Apr;54(4):238. doi: 10.11622/smedj.2013084.
4
Authors' Reply.
J Mol Diagn. 2018 Jan;20(1):125-126. doi: 10.1016/j.jmoldx.2017.11.002.
5
Reply to Senefeld and Hunter: Physiology in Medicine: Neuromuscular consequences of diabetic neuropathy. The authors' reply.
J Appl Physiol (1985). 2016 Jul 1;121(1):361. doi: 10.1152/japplphysiol.00423.2016.
6
Reply to: Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study".
Med Devices (Auckl). 2019 Mar 22;12:129-131. doi: 10.2147/MDER.S202581. eCollection 2019.
7
Authors' Reply to the Letter to the Editor: Reply to "Cognitive performance in women with fibromyalgia' by de Heredia-Torres and colleagues".
Aust Occup Ther J. 2017 Aug;64(4):E101. doi: 10.1111/1440-1630.12385.
8
Authors' Reply.
Am J Pathol. 2016 Aug;186(8):2234-2235. doi: 10.1016/j.ajpath.2016.06.001. Epub 2016 Jul 20.
9
Architecture and functioning of child and adolescent mental health services: a reply from Slovenia - Authors' reply.
Lancet Psychiatry. 2017 Sep;4(9):e20. doi: 10.1016/S2215-0366(17)30336-X.
10
Authors' reply.
IEEE Trans Med Imaging. 1985;4(2):122. doi: 10.1109/TMI.1985.4307706.
本文引用的文献
1
Does eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
Ann Gastroenterol. 2015 Apr-Jun;28(2):294.
2
Risk factors for gastroesophageal reflux disease: the role of diet.
Prz Gastroenterol. 2014;9(5):297-301. doi: 10.5114/pg.2014.46166. Epub 2014 Oct 19.
3
Patients with established gastro-esophageal reflux disease might benefit from eradication.
Ann Gastroenterol. 2014;27(4):352-356.
4
Dual Ambulatory pH Monitoring in Patients with Gastroesophageal Reflux Rendered Asymptomatic with Proton Pump Inhibitor Therapy.
Dig Dis Sci. 2015 May;60(5):1343-9. doi: 10.1007/s10620-014-3324-y. Epub 2014 Aug 19.
5
Can multichannel intraluminal pH-impedance monitoring be limited to 3 hours? Comparison between ambulatory 24-hour and post-prandial 3-hour recording.
Dis Esophagus. 2014 Nov-Dec;27(8):732-6. doi: 10.1111/dote.12161. Epub 2013 Nov 20.
Zotero 插件